Apollo Hospitals Enterprise Latest Share Price (APOLLOHOSP)
TODAY IN ONE LINE
APOLLOHOSP edged up 0.7% on average volume, in line with Nifty's 0.1% move, supported by recent strong earnings.
With a market cap of ₹1.28 L Cr., it trades at a P/E of 65.98. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Apollo Hospitals Enterprise flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Strong Price MomentumRobust returns of 23.1% over 1Y
- ●Earnings GrowthEPS (TTM) grew by a solid 35.6% YoY
- ●Consistent GrowthEPS compounded at 33.3% over 3 years
- ●Quarterly OutperformanceLatest quarter Sales up 18.1% and Profit up 35.9%
- ●High Capital EfficiencyROCE of 17.9% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 22.1%
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
Red Flags
- ●Expensive ValuationTrading at a high P/E ratio of 63.8x
- ●Promoter SellingPromoter holding decreased by 1.32% QoQ
- ●Rising Receivables vs SalesReceivables grew 17.7% outpacing sales growth of 14.3%
- ●Promoter Pledging DetectedPledge activity recorded on 30-Sep-2025 17:00
Latest Apollo Hospitals Enterprise News
What changed recently?
Recent events, corporate actions, and announcements.
Apollo Hospitals Enterprise Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Apollo Hospitals Enterprise Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Apollo Hospitals Enterprise Ltd trades at a P/E of 65.98× and P/B of 13.51×, against the Healthcare sector median P/E of 46.27×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Apollo Hospitals Enterprise Ltd technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Apollo Hospitals Enterprise Ltd — derived from the latest tape, not yesterday's close.
Apollo Hospitals Enterprise Ltd last traded at ₹8,974.5 with an intraday range of ₹8,880–₹9,015 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹8974.50| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 9303.00 | +328.50 | +3.66% |
| R3 | 9168.00 | +193.50 | +2.16% |
| R2 | 9091.50 | +117.00 | +1.30% |
| R1 | 9033.00 | +58.50 | +0.65% |
| PIVOT | 8956.50 | -18.00 | -0.20% |
| CURRENT | 8974.50 | — | — |
| S1 | 8898.00 | -76.50 | -0.85% |
| S2 | 8821.50 | -153.00 | -1.70% |
| S3 | 8763.00 | -211.50 | -2.36% |
| S4 | 8628.00 | -346.50 | -3.86% |
APOLLOHOSP is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: ₹8916–₹8975
Trading Inside opening range
Apollo Hospitals Enterprise Ltd financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Apollo Hospitals Enterprise Ltd — consolidated or standalone — with margins, YoY growth and key ratios inline.
Apollo Hospitals Enterprise Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1.28 L Cr. and reported EPS of ₹134.95.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 21,794 | 25,229 ▲ 15.8% |
| Sales Growth YoY %Derived | 14.35% | 15.76% |
| Other Income | 200 | 192 ▼ 4.3% |
| Total Income | 21,994 | 25,420 ▲ 15.6% |
| 11,310 | 13,076 ▲ 15.6% | |
| Gross ProfitDerived | 10,484 | 12,153 ▲ 15.9% |
| Gross Margin %Derived | 48.10% | 48.17% |
| 7,462 | 8,384 ▲ 12.3% | |
| EBITDA (Operating Profit)Derived | 3,022 | 3,769 ▲ 24.7% |
| OPM %Derived | 13.87% | 14.94% |
| 1,216 | 1,307 ▲ 7.4% | |
| Profit Before Tax (PBT) | 2,006 | 2,616 ▲ 30.4% |
| 534 | 658 ▲ 23.3% | |
| Effective Tax %Derived | 26.62% | 25.16% |
| Total Profit for Period | 1,505 | 2,003 ▲ 33.1% |
| Less: Non-controlling Interests | 59 | 61 ▲ 3.0% |
| Net Profit (Owner's PAT)Derived | 1,446 | 1,942 ▲ 34.3% |
| Net Profit Margin %Derived | 6.63% | 7.70% |
| PAT Growth YoY %Derived | 60.91% | 34.29% |
| Earnings Per Share (EPS ₹) | 100.56 | 135.04 ▲ 34.3% |
| Diluted Shares Outstanding (Cr) | 14 | 14 ▲ 0.0% |
| Share of Profit from Associates/JVs | 33 | 45 ▲ 36.1% |
| Other Comprehensive Income (Net of Tax) | -6 | 58 ▲ 1027.0% |
| Total Expenses (incl. D&A & Interest) | 19,988 | 22,804 ▲ 14.1% |
| Material Cost % of RevenueDerived | 12.64% | 12.05% |
| Employee Cost % of RevenueDerived | 12.71% | 11.89% |
| Other Cost % of RevenueDerived | 21.53% | 21.34% |
| Interest Coverage (x)Derived | 4.94x | 6.44x |
| Period | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 8,243 | 9,617 ▲ 16.7% | 11,247 ▲ 16.9% | 10,560 ▼ 6.1% | 14,663 ▲ 38.9% | 16,612 ▲ 13.3% | 19,059 ▲ 14.7% | 21,794 ▲ 14.3% | 25,229 ▲ 15.8% | |
| Sales Growth YoY %Derived | — | 16.67% | 16.94% | -6.11% | 38.85% | 13.30% | 14.73% | 14.35% | 15.76% | |
| Other Income | 32 | 31 ▼ 2.2% | 27 ▼ 14.2% | 45 ▲ 66.8% | 78 ▲ 73.7% | 90 ▲ 15.6% | 106 ▲ 17.7% | 200 ▲ 88.4% | 192 ▼ 4.3% | |
| Total Income | 8,276 | 9,649 ▲ 16.6% | 11,274 ▲ 16.8% | 10,605 ▼ 5.9% | 14,741 ▲ 39.0% | 16,703 ▲ 13.3% | 19,166 ▲ 14.7% | 21,994 ▲ 14.8% | 25,420 ▲ 15.6% | |
4,033 | 4,661 ▲ 15.6% | 5,499 ▲ 18.0% | 5,684 ▲ 3.4% | 7,573 ▲ 33.2% | 8,574 ▲ 13.2% | 9,806 ▲ 14.4% | 11,310 ▲ 15.3% | 13,076 ▲ 15.6% | ||
| Gross ProfitDerived | 4,211 | 4,957 ▲ 17.7% | 5,748 ▲ 16.0% | 4,876 ▼ 15.2% | 7,089 ▲ 45.4% | 8,038 ▲ 13.4% | 9,254 ▲ 15.1% | 10,484 ▲ 13.3% | 12,153 ▲ 15.9% | |
| Gross Margin %Derived | 51.08% | 51.54% | 51.11% | 46.17% | 48.35% | 48.39% | 48.55% | 48.10% | 48.17% | |
3,418 | 3,893 ▲ 13.9% | 4,161 ▲ 6.9% | 3,738 ▼ 10.1% | 4,904 ▲ 31.2% | 5,989 ▲ 22.1% | 6,863 ▲ 14.6% | 7,462 ▲ 8.7% | 8,384 ▲ 12.3% | ||
| EBITDA (Operating Profit)Derived | 793 | 1,064 ▲ 34.1% | 1,587 ▲ 49.2% | 1,137 ▼ 28.3% | 2,185 ▲ 92.1% | 2,050 ▼ 6.2% | 2,391 ▲ 16.6% | 3,022 ▲ 26.4% | 3,769 ▲ 24.7% | |
| OPM %Derived | 9.62% | 11.06% | 14.11% | 10.77% | 14.90% | 12.34% | 12.54% | 13.87% | 14.94% | |
654 | 723 ▲ 10.5% | 1,351 ▲ 86.9% | 1,083 ▼ 19.8% | 1,273 ▲ 17.6% | 996 ▼ 21.8% | 1,138 ▲ 14.3% | 1,216 ▲ 6.8% | 1,307 ▲ 7.4% | ||
| Profit Before Tax (PBT) | 171 | 373 ▲ 117.6% | 660 ▲ 77.2% | 221 ▼ 66.6% | 1,578 ▲ 615.0% | 1,144 ▼ 27.5% | 1,363 ▲ 19.1% | 2,006 ▲ 47.2% | 2,616 ▲ 30.4% | |
112 | 173 ▲ 54.9% | 225 ▲ 29.9% | 85 ▼ 62.4% | 477 ▲ 463.2% | 256 ▼ 46.3% | 446 ▲ 73.9% | 534 ▲ 19.9% | 658 ▲ 23.3% | ||
| Effective Tax %Derived | 65.35% | 46.53% | 34.11% | 38.38% | 30.23% | 22.40% | 32.70% | 26.62% | 25.16% | |
| Total Profit for Period | 60 | 200 ▲ 236.1% | 432 ▲ 115.7% | 137 ▼ 68.3% | 1,108 ▲ 710.4% | 845 ▼ 23.8% | 935 ▲ 10.7% | 1,505 ▲ 61.0% | 2,003 ▲ 33.1% | |
| Less: Non-controlling Interests | -58 | -36 ▲ 38.0% | -23 ▲ 35.5% | -14 ▲ 41.2% | 53 ▲ 487.9% | 26 ▼ 51.7% | 36 ▲ 42.7% | 59 ▲ 62.6% | 61 ▲ 3.0% | |
| Net Profit (Owner's PAT)Derived | 117 | 236 ▲ 101.0% | 455 ▲ 92.7% | 150 ▼ 66.9% | 1,056 ▲ 602.0% | 819 ▼ 22.4% | 899 ▲ 9.7% | 1,446 ▲ 60.9% | 1,942 ▲ 34.3% | |
| Net Profit Margin %Derived | 1.42% | 2.45% | 4.05% | 1.42% | 7.20% | 4.93% | 4.71% | 6.63% | 7.70% | |
| PAT Growth YoY %Derived | — | 101.03% | 92.73% | -66.95% | 602.01% | -22.41% | 9.71% | 60.91% | 34.29% | |
| Earnings Per Share (EPS ₹) | 8.44 | 16.97 ▲ 101.1% | 32.70 ▲ 92.7% | 10.46 ▼ 68.0% | 73.42 ▲ 601.9% | 56.97 ▼ 22.4% | 62.50 ▲ 9.7% | 100.56 ▲ 60.9% | 135.04 ▲ 34.3% | |
| Diluted Shares Outstanding (Cr) | 14 | 14 ▲ 0.0% | 14 ▲ 0.0% | 14 ▲ 3.3% | 14 ▲ 0.0% | 14 ▲ 0.0% | 14 ▲ 0.0% | 14 ▲ 0.0% | 14 ▲ 0.0% | |
| Share of Profit from Associates/JVs | 0 | 1 ▲ 326.1% | -3 ▼ 417.3% | 1 ▲ 124.8% | 7 ▲ 854.5% | -43 ▼ 687.1% | 18 ▲ 141.7% | 33 ▲ 83.3% | 45 ▲ 36.1% | |
| Other Comprehensive Income (Net of Tax) | -17 | -29 ▼ 69.3% | -1 ▲ 97.9% | 15 ▲ 2655.0% | -10 ▼ 163.4% | -13 ▼ 36.5% | -10 ▲ 21.6% | -6 ▲ 39.4% | 58 ▲ 1027.0% | |
| Total Expenses (incl. D&A & Interest) | 8,104 | 9,276 ▲ 14.5% | 10,614 ▲ 14.4% | 10,384 ▼ 2.2% | 13,163 ▲ 26.8% | 15,559 ▲ 18.2% | 17,803 ▲ 14.4% | 19,988 ▲ 12.3% | 22,804 ▲ 14.1% | |
| Material Cost % of RevenueDerived | 17.72% | 17.10% | 16.09% | 15.37% | 18.32% | 13.75% | 12.88% | 12.64% | 12.05% | |
| Employee Cost % of RevenueDerived | 17.04% | 16.62% | 16.48% | 15.16% | 12.18% | 12.90% | 13.08% | 12.71% | 11.89% | |
| Other Cost % of RevenueDerived | 24.42% | 23.86% | 20.52% | 20.24% | 21.26% | 23.14% | 22.92% | 21.53% | 21.34% | |
| Interest Coverage (x)Derived | 1.47x | 2.04x | 1.82x | 1.26x | 4.18x | 3.77x | 3.79x | 4.94x | 6.44x |
Apollo Hospitals Enterprise segment analysis : revenue and profit mix.
Disclosed business segments at Apollo Hospitals Enterprise with their share of revenue and profit, switchable between consolidated and standalone reporting.
Apollo Hospitals Enterprise discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Apollo Hospitals Enterprise Ltd.
Our AI distills the core fundamental drivers supporting Apollo Hospitals Enterprise Ltd, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Apollo Hospitals Enterprise Ltd's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Latest quarterly EPS grew 35.9% YoY, demonstrating exceptional earnings momentum and profitability acceleration.
ROE 22.10% and ROCE 17.90% substantially exceed sector benchmarks, signaling efficient capital deployment.
Market cap ₹1.28 LCr establishes Apollo as India's largest integrated healthcare leader with scale advantages.
Quarterly revenue growth 18.10% YoY reflects robust operational performance across hospital and retail segments.
Operating cash flow ₹2,136 Cr supports debt servicing, capex investments, and shareholder distributions sustainably.
Key Risks.
P/E 63.83x elevated versus peer median, limiting margin of safety for new investors at current valuations.
Operating margin 11.47% lags peer range of 17–21% significantly despite integrated business model scale.
Dividend yield 0.23% insufficient for income-focused investor portfolios seeking meaningful returns.
Total debt ₹0.08 LCr with D/E 0.90x indicates moderate leverage exposure for healthcare sector operations.
FII holdings eased from 49.09% to 45.37%, signals cautious foreign investor sentiment over two years.
Flip Conditions.
Valuation risk. a P/E above 86 (~1.9× the sector multiple of 46.3) would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.40. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 17% would indicate weaker capital compounding.
Apollo Hospitals Enterprise Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Apollo Hospitals Enterprise Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Apollo Hospitals Enterprise Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Apollo Hospitals Enterprise Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Apollo Hospitals Enterprise Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Apollo Hospitals Enterprise Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Apollo Hospitals Enterprise Ltd stood at 65.7% of traded volume, against a 20-day average of 61.0%.
Apollo Hospitals Enterprise announcements: results, concalls, ratings, M&A.
Filings Apollo Hospitals Enterprise sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Apollo Hospitals Enterprise files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 139 documents below.
General Updates
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates
Shareholders meeting
Apollo Hospitals Enterprise Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 25, 2026
Analysts/Institutional Investor Meet/Con. Call Updates
Apollo Hospitals Enterprise Limited has informed the Exchange about Schedule of meet
Updates
Apollo Hospitals Enterprise Limited has informed the Exchange regarding 'Certificate under Regulation 74(5) for the period ended 30th June 2026'.
Scheme of Arrangement
Apollo Hospitals Enterprise Limited has informed the Exchange about Scheme of Arrangement
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Analysts/Institutional Investor Meet/Con. Call Updates
Analysts/Institutional Investor Meet/Con. Call Updates
Apollo Hospitals Enterprise dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Apollo Hospitals Enterprise has declared, sequenced by announce and record date.
Apollo Hospitals Enterprise corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
Apollo Hospitals Enterprise insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Apollo Hospitals Enterprise as reported to SEBI — buying and selling signals from the people who know the business best.
Apollo Hospitals Enterprise insider activity below tracks 5 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| K VISHWESHWAR REDDY | Insider | 04 Apr 2025 | buy | +1.50 L | ₹100.72 Cr. | ₹6,714.67 |
| PPN POWER GENERATING CO PVT LTD | Insider | 28 Mar 2025 | buy | +1.3 K | ₹87 L | ₹6,556.14 |
| PPN POWER GENERATING CO PVT LTD | Insider | 24 Mar 2025 | buy | +4.5 K | ₹3.01 Cr. | ₹6,688.89 |
| KARTHIK ANAND | Insider | 19 Mar 2025 | buy | +929 | ₹59.6 L | ₹6,415.50 |
| SUNEETA REDDY | Insider | 11 Mar 2025 | buy | +40.0 K | ₹24.54 Cr. | ₹6,135.00 |
About Apollo Hospitals Enterprise Ltd: business, sector, key facts.
What Apollo Hospitals Enterprise Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Apollo Hospitals Enterprise Ltd operates in the Hospital industry under the Healthcare sector, listed as NSE: APOLLOHOSP, BSE: 508869.
Apollo Hospitals Enterprise Limited is a leading healthcare provider in India with an international presence. The company's core business revolves around delivering a wide spectrum of healthcare services, encompassing primary, secondary, and tertiary care. This includes a vast array of specialties, ranging from cardiology and oncology to neurosciences and robotic surgery, covering virtually all medical disciplines. Their facilities offer services like transplants, emergency care, and a comprehensive range of diagnostic procedures.
Apollo operates through several distinct segments. The primary segment, Healthcare Services, focuses on its network of hospitals and specialized facilities. Retail Health & Diagnostics encompasses the company's extensive network of pharmacies, clinics, diagnostic centers, and other retail healthcare outlets. The Digital Health & Pharmacy Distribution segment leverages technology through platforms like Apollo 24/7, its mobile health application, and www.apollopharmacy.in, its online pharmacy, to expand access and convenience. Finally, the "Others" segment encompasses diverse activities such as project consultancy, health insurance, medical colleges, and research services.
Beyond its core hospital and clinical services, Apollo's business model is diversified. It includes a substantial retail presence with pharmacies, primary care clinics, and specialized centers for areas such as birthing, dialysis, diabetes management, and dentistry. The company also engages in bio-banking of tissues, indicating a commitment to research and advanced medical technologies. Their educational arm, Medvarsity, provides e-learning opportunities, while their consultancy services extend beyond their direct patient care operations.
In summary, Apollo Hospitals' business strategy focuses on integrated healthcare delivery, combining advanced medical technologies with a broad network of facilities and digital platforms. This integrated approach encompasses a full spectrum of care, from primary healthcare to highly specialized treatments, and utilizes technological advancements to extend its reach and improve accessibility to healthcare services for a wide patient base. Their expansion into diverse related areas such as education, research, and retail demonstrates a comprehensive approach to the healthcare market.
Go deeper on Apollo Hospitals Enterprise
- Apollo Hospitals Enterprise resultsQuarter-by-quarter revenue, profit, EPS and margins for Apollo Hospitals Enterprise.
- Apollo Hospitals Enterprise dividendEvery dividend Apollo Hospitals Enterprise has declared, with ex-dates and yield.
- Apollo Hospitals Enterprise shareholdingPromoter, FII and DII holding in Apollo Hospitals Enterprise, quarter by quarter.
- Apollo Hospitals Enterprise financialsApollo Hospitals Enterprise profit & loss, balance sheet and cash flow by year.
- Apollo Hospitals Enterprise technical analysisPivots, CPR and live indicator readings for Apollo Hospitals Enterprise.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Dr Agarwal's Health Care (AGARWALEYE) Share PricePeer
- Artemis Medicare Services (ARTEMISMED) Share PricePeer
- Aster DM Healthcare (ASTERDM) Share PricePeer
- Fortis Healthcare (FORTIS) Share PricePeer
- GPT Healthcare (GPTHEALTH) Share PricePeer
- Stocks near 52-week high (breakout watch)Screener
- Breakout Trader strategy playbookStrategy
- Other overvalued NSE stocksScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Apollo Hospitals Enterprise Ltd (APOLLOHOSP).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Apollo Hospitals Enterprise Ltd (APOLLOHOSP)?
The current share price of Apollo Hospitals Enterprise Ltd (APOLLOHOSP) is ₹8,974.50. Today, the stock has gained by ₹64.50 (0.72%), trading in a range of ₹8,880.00 to ₹9,015.00. The stock opened at ₹8,947.00 with a trading volume of 3,99,856 shares.
02Is Apollo Hospitals Enterprise Ltd stock a good investment for long-term?
Apollo Hospitals Enterprise Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1.28 L Cr., P/E ratio of 65.98, ROE of 22.1%, and ROCE of 17.9%. The dividend yield stands at 0.23%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Apollo Hospitals Enterprise Ltd stock?
The 52-week high price of Apollo Hospitals Enterprise Ltd (APOLLOHOSP) is ₹9,050.00, while the 52-week low is ₹6,696.50. Currently trading at ₹8,974.50, the stock is 34.02% above its 52-week low and 0.83% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Apollo Hospitals Enterprise Ltd stock at the current price?
Whether to buy Apollo Hospitals Enterprise Ltd stock at ₹8,974.50 depends on multiple factors. The stock is currently trading with a P/E ratio of 65.98 and P/B ratio of 13.51. Today's performance shows a gain of 0.72%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Apollo Hospitals Enterprise Ltd and when is the next dividend?
Apollo Hospitals Enterprise Ltd offers a dividend yield of 0.23%, which means for every ₹100 invested at the current price of ₹8,974.50, you can expect to receive approximately ₹0.23 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Apollo Hospitals Enterprise Ltd?
Apollo Hospitals Enterprise Ltd's key financial metrics include: P/E Ratio: 65.98, P/B Ratio: 13.51, ROE: 22.1%, ROCE: 17.9%, Dividend Yield: 0.23%, EPS: ₹134.95, Book Value: ₹659.33, and Debt-to-Equity: 0.9. The company's market cap stands at ₹1.28 L Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Apollo Hospitals Enterprise Ltd stock performing today in the market?
Apollo Hospitals Enterprise Ltd stock opened at ₹8,947.00 and is currently trading at ₹8,974.50, showing a gain of ₹64.50 (0.72%). The intraday high is ₹9,015.00 and low is ₹8,880.00. The trading volume stands at 3,99,856 shares, indicating moderate market participation today.
08What is the P/E ratio of Apollo Hospitals Enterprise Ltd and what does it indicate?
Apollo Hospitals Enterprise Ltd has a Price-to-Earnings (P/E) ratio of 65.98, which means investors are willing to pay 65.98 for every ₹1 of earnings. With an EPS of ₹134.95, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Apollo Hospitals Enterprise Ltd (APOLLOHOSP) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.